No abstract

Purpose To develop new artificial neural networks (ANNs) to accelerate slice encoding for metal artifact correction (SEMAC) MRI. Methods Eight titanium phantoms and 77 patients after brain tumor surgery involving metallic neuro‐plating instruments were scanned using SEMAC at a 3T Skyra scanner. For the phantoms, proton‐density, T1‐, and T2‐weighted images were acquired for developing both multilayer perceptron (MLP) and convolutional neural network (CNN). For the patients, T2‐weighted images were acquired for developing CNN. All networks were trained with the SEMAC factor 4 or 6 as input and the factor 12 as label, yielding an acceleration factor of 3 or 2. Performance of the CNN model was compared against parallel imaging and compressed sensing on the phantom datasets. Two extra T1‐weighted in vivo sets were acquired to investigate generalizability of the models to different contrasts. Results Both multilayer perceptron and CNN provided artifact‐suppressed images better than the input images and comparable to the label images visually and quantitatively, a trend observable regardless of input SEMAC factor and image type (P < .01). CNN suppressed the artifacts better than multilayer perceptron, parallel imaging, and compressed sensing (P < .01). Tests on the patient datasets demonstrated clear metal artifact suppression visually and quantitatively (P < .01). Tests on T1 datasets also demonstrated clear visual metal artifact suppression. Conclusion Our study introduced a new effective way of artificial neural networks to accelerate SEMAC MRI while maintaining the comparable quality of metal artifact suppression. Application on the preliminary patient datasets proved the feasibility in clinical usage, which warrants further investigation.

Brain tumor segmentation is essential for the diagnosis and prognosis of patients with gliomas. The brain tumor segmentation challenge has continued to provide a great source of data to develop automatic algorithms to perform the task. This paper describes our contribution to the 2021 competition. We developed our methods based on nn-UNet, the winning entry of last year competition. We experimented with several modifications, including using a larger network, replacing batch normalization with group normalization, and utilizing axial attention in the decoder. Internal 5-fold cross validation as well as online evaluation from the organizers showed the effectiveness of our approach, with minor improvement in quantitative metrics when compared to the baseline. The proposed models won first place in the final ranking on unseen test data. The codes, pretrained weights, and docker image for the winning submission are publicly available. 1

We aimed to evaluate and compare the qualities of synthetic computed tomography (sCT) generated by various deep-learning methods in volumetric modulated arc therapy (VMAT) planning for prostate cancer. Simulation computed tomography (CT) and T2-weighted simulation magnetic resonance image from 113 patients were used in the sCT generation by three deep-learning approaches: generative adversarial network (GAN), cycle-consistent GAN (CycGAN), and reference-guided CycGAN (RgGAN), a new model which performed further adjustment of sCTs generated by CycGAN with available paired images. VMAT plans on the original simulation CT images were recalculated on the sCTs and the dosimetric differences were evaluated. For soft tissue, a significant difference in the mean Hounsfield unites (HUs) was observed between the original CT images and only sCTs from GAN (p = 0.03). The mean relative dose differences for planning target volumes or organs at risk were within 2% among the sCTs from the three deep-learning approaches. The differences in dosimetric parameters for D98% and D95% from original CT were lowest in sCT from RgGAN. In conclusion, HU conservation for soft tissue was poorest for GAN. There was the trend that sCT generated from the RgGAN showed best performance in dosimetric conservation D98% and D95% than sCTs from other methodologies.